Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 20 | Next »

1

Journal article

Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy

Evans, JS, Beaumont, J, Braga, M, et al.
2022-10-05

2

Journal article

Uptake of COVID-19 vaccination in people with blood cancer: population-level cohort study of 12 million patients in England

Hirst, J, Mi, E, Copland, E, et al.
2023-02-09

3

Journal article

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma

Hemstock, M, Kupas, K, Roskell, N, et al.
2020-05-04

4

Conference item

Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer

Lord, S, Cheng, WC, Liu, D, et al.
2018-11-01

5

Journal article

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma

Thomas, A, Virdee, PS, Martin, E, et al.
2019-11-22

6

Journal article

Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

Jones, D, Mistry, P, Dalby, M, et al.
2019-11-30

7

Journal article

Combining conventional therapy with immunotherapy: A risky business?

Coosemans, A, Vankerckhoven, A, Baert, T, et al.
2019-04-06

8

Conference item

Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis

Sasson, SC, Zaunders, J, Nahar, K, et al.
2019-04-08

9

Journal article

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma

McGowan, D, Skwarski, M, Bradley, K, et al.
2019-04-13

10

Journal article

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity

Postel-Vinay, S, Herbschleb, K, Massard, C, et al.
2019-01-31

TO TOP